FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019937567> ?p ?o ?g. }

• W2019937567 endingPage "566" @default.
• W2019937567 startingPage "562" @default.
• W2019937567 abstract "In women suffering from polycystic ovary syndrome (PCOS), correction of hyperinsulinemia results enhances spontaneous ovulation or alternatively, the responsiveness to ovulation induction agents such as clomiphene citrate (CC). We investigated the effect of rosiglitazone maleate on ovulation induction in overweight and obese, CC-resistant women with PCOS.Double-blind, randomized, placebo-controlled trial.Academic reproductive endocrinology clinic.Overweight and obese women with clinical and laboratory manifestations of PCOS who desired pregnancy and were resistant to CC.Twenty-five women were randomized into two treatment groups. Subjects in Group I (n = 12) were randomized to receive rosiglitazone 4 mg b.i.d. with a placebo on cycle days 5-9. Group II (n = 13) was randomized to receive rosiglitazone 4 mg b.i.d. with CC on cycle days 5-9. The duration of the study was 2 months.The primary outcome was ovulation as defined by luteal serum progesterone greater than 5 ng/dL assessed on days 21, 24, and 28 of the cycle. Secondary outcomes were pregnancy and changes in insulin sensitivity, serum lipoproteins, and androgens.Overall, 14 of 25 (56%) women, who were previously resistant to CC, successfully ovulated. In subjects taking rosiglitazone alone (Group I), 4 of 12 (33%) subjects ovulated compared with 10 of 13 (77%) women randomized to rosiglitazone with CC (Group II) (P=.04, Fisher's exact). One subject in Group I became pregnant, resulting in one uncomplicated live birth; two subjects in Group II conceived, with one successful live birth and one first trimester, spontaneous abortion. For all subjects, fasting insulin declined from 29.4 +/- 13.8 microU/mL to 17.3 +/- 7.8 microU/mL after rosiglitazone (P=.003, paired t-test). Although mean levels of total testosterone (T) and dehydroepiandrosterone sulfate (DHEAS) did not decline significantly, sex hormone-binding globulin (SHBG) did increase from 0.7 +/- 0.3 microg/dL to 1.0 +/- 0.3 microg/dL after rosiglitazone therapy (P=.001, paired t test). There was also a decrease in luteinizing hormone (LH) from 9.4 +/- 6.3 mU/mL to 7.2 +/- 3.7 mU/mL (P=.01). Lipoproteins including total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides did not change.Short-term rosiglitazone therapy enhances both spontaneous and clomiphene-induced ovulation in overweight and obese women with PCOS. Rosiglitazone therapy improves insulin sensitivity and decreases hyperandrogenemia primarily through increases in SHBG." @default.
• W2019937567 created "2016-06-24" @default.
• W2019937567 creator A5028347976 @default.
• W2019937567 creator A5062243173 @default.
• W2019937567 creator A5063501918 @default.
• W2019937567 creator A5082771103 @default.
• W2019937567 creator A5087175465 @default.
• W2019937567 date "2003-03-01" @default.
• W2019937567 modified "2023-10-16" @default.
• W2019937567 title "Effect of rosiglitazone on spontaneous and clomiphene citrate–induced ovulation in women with polycystic ovary syndrome" @default.
• W2019937567 cites W1977336162 @default.
• W2019937567 cites W1989689562 @default.
• W2019937567 cites W2000821877 @default.
• W2019937567 cites W2027702484 @default.
• W2019937567 cites W2047591801 @default.
• W2019937567 cites W2053222301 @default.
• W2019937567 cites W2057907412 @default.
• W2019937567 cites W2065671703 @default.
• W2019937567 cites W2087286513 @default.
• W2019937567 cites W2123925343 @default.
• W2019937567 cites W2140122568 @default.
• W2019937567 cites W2140603676 @default.
• W2019937567 cites W2154909966 @default.
• W2019937567 cites W2314633857 @default.
• W2019937567 cites W2320006945 @default.
• W2019937567 cites W2400946135 @default.
• W2019937567 doi "https://doi.org/10.1016/s0015-0282(02)04843-4" @default.
• W2019937567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12620440" @default.
• W2019937567 hasPublicationYear "2003" @default.
• W2019937567 type Work @default.
• W2019937567 sameAs 2019937567 @default.
• W2019937567 citedByCount "180" @default.
• W2019937567 countsByYear W20199375672013 @default.
• W2019937567 countsByYear W20199375672014 @default.
• W2019937567 countsByYear W20199375672015 @default.
• W2019937567 countsByYear W20199375672016 @default.
• W2019937567 countsByYear W20199375672017 @default.
• W2019937567 countsByYear W20199375672018 @default.
• W2019937567 countsByYear W20199375672020 @default.
• W2019937567 countsByYear W20199375672021 @default.
• W2019937567 countsByYear W20199375672022 @default.
• W2019937567 countsByYear W20199375672023 @default.
• W2019937567 crossrefType "journal-article" @default.
• W2019937567 hasAuthorship W2019937567A5028347976 @default.
• W2019937567 hasAuthorship W2019937567A5062243173 @default.
• W2019937567 hasAuthorship W2019937567A5063501918 @default.
• W2019937567 hasAuthorship W2019937567A5082771103 @default.
• W2019937567 hasAuthorship W2019937567A5087175465 @default.
• W2019937567 hasBestOaLocation W20199375671 @default.
• W2019937567 hasConcept C126322002 @default.
• W2019937567 hasConcept C134018914 @default.
• W2019937567 hasConcept C168563851 @default.
• W2019937567 hasConcept C2777391703 @default.
• W2019937567 hasConcept C2777688143 @default.
• W2019937567 hasConcept C2777702977 @default.
• W2019937567 hasConcept C2778641792 @default.
• W2019937567 hasConcept C2779234561 @default.
• W2019937567 hasConcept C2779306644 @default.
• W2019937567 hasConcept C2780152017 @default.
• W2019937567 hasConcept C2781230225 @default.
• W2019937567 hasConcept C29456083 @default.
• W2019937567 hasConcept C3018442814 @default.
• W2019937567 hasConcept C54355233 @default.
• W2019937567 hasConcept C71315377 @default.
• W2019937567 hasConcept C71924100 @default.
• W2019937567 hasConcept C86803240 @default.
• W2019937567 hasConceptScore W2019937567C126322002 @default.
• W2019937567 hasConceptScore W2019937567C134018914 @default.
• W2019937567 hasConceptScore W2019937567C168563851 @default.
• W2019937567 hasConceptScore W2019937567C2777391703 @default.
• W2019937567 hasConceptScore W2019937567C2777688143 @default.
• W2019937567 hasConceptScore W2019937567C2777702977 @default.
• W2019937567 hasConceptScore W2019937567C2778641792 @default.
• W2019937567 hasConceptScore W2019937567C2779234561 @default.
• W2019937567 hasConceptScore W2019937567C2779306644 @default.
• W2019937567 hasConceptScore W2019937567C2780152017 @default.
• W2019937567 hasConceptScore W2019937567C2781230225 @default.
• W2019937567 hasConceptScore W2019937567C29456083 @default.
• W2019937567 hasConceptScore W2019937567C3018442814 @default.
• W2019937567 hasConceptScore W2019937567C54355233 @default.
• W2019937567 hasConceptScore W2019937567C71315377 @default.
• W2019937567 hasConceptScore W2019937567C71924100 @default.
• W2019937567 hasConceptScore W2019937567C86803240 @default.
• W2019937567 hasIssue "3" @default.
• W2019937567 hasLocation W20199375671 @default.
• W2019937567 hasLocation W20199375672 @default.
• W2019937567 hasOpenAccess W2019937567 @default.
• W2019937567 hasPrimaryLocation W20199375671 @default.
• W2019937567 hasRelatedWork W1973642435 @default.
• W2019937567 hasRelatedWork W2012030386 @default.
• W2019937567 hasRelatedWork W2096682790 @default.
• W2019937567 hasRelatedWork W2330595372 @default.
• W2019937567 hasRelatedWork W2391704906 @default.
• W2019937567 hasRelatedWork W2412332717 @default.
• W2019937567 hasRelatedWork W2749623095 @default.
• W2019937567 hasRelatedWork W2804464658 @default.
• W2019937567 hasRelatedWork W3032430598 @default.
• W2019937567 hasRelatedWork W4210556015 @default.

• next